Skip to main content
. 2018 Apr 18;9(5):446. doi: 10.1038/s41419-018-0474-4

Fig. 7. Inhibition of the CDK4/6-Rb pathway by palbociclib reduced human synovial sarcoma cell migration in vitro.

Fig. 7

After exposure to 1 µM of palbociclib for the indicated time, the cell migration of SYO-1 and Fuji cells was determined by wound healing assays. a Representative images of SYO-1 cell migration after palbociclib treatment for 24, 48, and 72 h (scale bar, 50 μm). b Representative images of Fuji cell migration after palbociclib treatment for 24, 48, and 72 h (scale bar, 50 μm). c Cell migration distance of SYO-1 cells was measured after palbociclib treatment. d Cell migration distance of Fuji cells was measured after palbociclib treatment. ***P < 0.001 compared with the cell only group